Leave on for no more than 10 minutes
Product Information Chemical Data Analyte Name Ipamorelin Acetate Molecular Formula C38H49N9O5 x(C2H4O2 ) Molecular Weight 711.856005 SMILES O=C(N[C@@H](C(N[C@@H](C(N[C@H](C(N)=O)CCCCN)=O)CC1=CC=CC=C1)=O)CC2=CC(C=CC=C3)=C3C=C2)[C@@H](NC(C(C)(N)C)=O)CC4=CN=CN4 InChI InChI=1S/C38H49N9O5/c1-38(2,41)37(52)47-32(21-28-22-42-23-43-28)36(51)46-31(20-25-15-16-26-12-6-7-13-27(26)18-25)35(50)45-30(19-24-10-4-3-5-11-24)34(49)44-29(33(40)48)14-8-9-17-39/h3-7,10-13,15-16,18,22-23,29-32H,8-9,14,17,19-21,39,41H2,1-2H3,(H2,40,48)(H,42,43)(H,44,49)(H,45,50)(H,46,51)(H,47,52)/t29-,30+,31+,32-/m0/s1 Alternate CAS Number Free form: 170851-70-4 Product Data Storage Temperature -20C Shipping Temperature Room Temperature
There is evidence in the broader dataset that this might be correct
Putting the evidence side by side Here is the blunt comparison: AOD 9604: 2.6 kg weight loss in 12 weeks (best result), failed six clinical trials, development terminated Semaglutide: 15 to 17 percent body weight loss over 68 weeks, FDA approved, thousands of study participants, consistent results across multiple trials There is no way to frame this comparison that puts AOD 9604 on equal footing with semaglutide when it comes to clinical evidence